 
							
					
															
					
					 by Caroline Fife, M.D. | Oct 27, 2025 | Fight the Good Fight, Obesity & Wound Care
I know by now everyone must think that I secretly work for one of the pharmaceutical companies that sells GLP-1-RAs but honestly, I am just a fascinated spectator. Obesity and its related diseases are a major contributor to the chronic wound epidemic and after more...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Oct 22, 2025 | Fight the Good Fight, Obesity & Wound Care
Dr. Fife, Surprise! When industry changes the definition of obesity, they find more obesity! We needed something better than the BMI, but this is not the solution. If Waist:Hip ratio is used, the goal should not be “ideal for young people” because it is...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Oct 20, 2025 | Fight the Good Fight, Obesity & Wound Care
I don’t know if this is good news or bad news, but the American population just got fatter thanks to a new definition of obesity in a study published in JAMA Open Network. If you are a “glass half full” sort of person, then the new definition might make it easier to...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Sep 17, 2025 | Fight the Good Fight, Obesity & Wound Care
I have been paying close attention to the news about glucagon-like peptide 1 (GLP-1) agonist medications because they may provide a ray of hope for many patients with chronic wounds – over 60% of whom are obese and nearly half of whom have diabetes. However, I also...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Mar 14, 2025 | Fight the Good Fight, Obesity & Wound Care
By now I suppose everyone thinks that I am employed by one of the GLP-1RA marketing firms. I have still not decided exactly where to fit this exciting new drug in the armamentarium of a wound care practitioner, but so far the drugs have potential use in just about...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Jan 17, 2025 | Fight the Good Fight, Obesity & Wound Care
JAMA has published a patient handout explaining the categories of weight loss medications. You have to sign in to download the PDF, but anyone can view it in the link. The need for clinicians of all types to be engaged in conversations with patients about obesity is...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Dec 6, 2024 | Fight the Good Fight, Obesity & Wound Care, The Patient's Voice
I saw this patient almost 5 years ago, but her case is one of those that I can’t get out of my mind. I now understand what I was looking at, but I didn’t understand it at the time. The woman was in her late 60’s and an orthopedic surgeon sent her to me because she...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Nov 13, 2024 | Fight the Good Fight, Nutrition & Wound Healing, Obesity & Wound Care
I have no affiliation with any pharmaceutical company, and I continue to be cautious about the Glucagon-like peptide receptor agonist (GLP-1 RA) craze. However, I am paying attention to this family of drugs because for more than three decades I have watched with a...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Nov 4, 2024 | Fight the Good Fight, Obesity & Wound Care
There’s a new concept for calculating obesity called the Body Roundness Index (BRI), which may be a more accurate way to understand obesity and healthcare risk than the Body Mass Index (BMI). That’s because visceral obesity is an important risk factor associated with...				
					
			
					
											
								 
							
					
															
					
					 by Caroline Fife, M.D. | Nov 4, 2024 | COVID-19, Fight the Good Fight, Obesity & Wound Care
A large retrospective study just published in JAMA Open Network suggests that elevated body mass index (BMI) in both children and young adults was associated with an increased risk of post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID. This study is...